RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+9.18%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.19B
AUM Growth
+$4.19B
(+0.79%)
Cap. Flow
+$31.2M
Cap. Flow
% of AUM
0.75%
Top 10 Holdings %
Top 10 Hldgs %
34.6%
Holding
124
New
3
Increased
47
Reduced
8
Closed
3
Top Buys
| 1 |
Mineralys Therapeutics
MLYS
|
$18.3M |
| 2 |
Biomea Fusion
BMEA
|
$17.6M |
| 3 |
Revolution Medicines
RVMD
|
$15.2M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$14.5M |
| 5 |
Pliant Therapeutics
PLRX
|
$13.1M |
Top Sells
| 1 |
Baxter International
BAX
|
$58.6M |
| 2 |
Penumbra
PEN
|
$20.8M |
| 3 |
Align Technology
ALGN
|
$18.4M |
| 4 |
Immunocore
IMCR
|
$15.8M |
| 5 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$13.7M |
Sector Composition
| 1 | Healthcare | 97.18% |
| 2 | Consumer Staples | 1.05% |
| 3 | Industrials | 0.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
BioMarin Pharmaceuticals
BMRN
$11.2B
| $25.7M | 0.61% | 264,500 | – | – |
|
|
SWAV
52
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $25M | 0.6% | 115,100 | – | – |
|
53
Legend Biotech
LEGN
$6.41B
| $22.1M | 0.53% | 458,265 +7,799 | +2% | +$376K |
|
54
Lifestance Health
LFST
$2.13B
| $21.5M | 0.51% | 2,900,000 +200,000 | +7% | +$1.49M |
|
55
CONMED
CNMD
$1.68B
| $21.3M | 0.51% | 205,000 | – | – |
|
56
BioCryst Pharmaceuticals
BCRX
$1.74B
| $19.5M | 0.46% | 2,334,085 +443,348 | +23% | +$3.7M |
|
|
AMYT
57
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $19.3M | 0.46% | 1,325,625 | – | – |
|
58
Azenta
AZTA
$1.4B
| $19.2M | 0.46% | 431,200 +79,700 | +23% | +$3.56M |
|
|
INZY
59
DELISTED
Inozyme Pharma
INZY
| $18.4M | 0.44% | 3,214,900 +128,873 | +4% | +$738K |
|
|
60
Mineralys Therapeutics
MLYS
$1.03B
| $18.3M | 0.44% | +1,167,492 | New | +$18.3M |
|
61
Compass Therapeutics
CMPX
$483M
| $18M | 0.43% | 5,513,788 +180,600 | +3% | +$591K |
|
62
Dynavax Technologies
DVAX
$1.19B
| $17.8M | 0.42% | 1,813,758 | – | – |
|
63
Immatics
IMTX
$619M
| $17.3M | 0.41% | 2,513,923 +239,139 | +11% | +$1.65M |
|
64
Mersana Therapeutics
MRSN
$36.5M
| $16.9M | 0.4% | 4,103,803 | – | – |
|
65
Cytokinetics
CYTK
$4.23B
| $15.8M | 0.38% | 447,600 +4,600 | +1% | +$162K |
|
66
Collegium Pharmaceutical
COLL
$1.22B
| $15.6M | 0.37% | 650,000 -75,000 | -10% | -$1.8M |
|
|
67
Revolution Medicines
RVMD
$7.1B
| $15.2M | 0.36% | +702,712 | New | +$15.2M |
|
68
Celldex Therapeutics
CLDX
$1.47B
| $15.2M | 0.36% | 421,504 | – | – |
|
69
Warby Parker
WRBY
$3.2B
| $13.8M | 0.33% | 1,300,000 +81,025 | +7% | +$858K |
|
|
70
Pliant Therapeutics
PLRX
$101M
| $13.1M | 0.31% | +491,221 | New | +$13.1M |
|
71
AnaptysBio
ANAB
$569M
| $12.5M | 0.3% | 576,600 | – | – |
|
72
Amicus Therapeutics
FOLD
$2.34B
| $11.8M | 0.28% | 1,063,806 | – | – |
|
|
KDNY
73
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $11.7M | 0.28% | 507,512 | – | – |
|
|
EDAP
74
EDAP TMS
EDAP
$84.5M
| $11.4M | 0.27% | 1,030,000 +120,000 | +13% | +$1.33M |
|
75
Relay Therapeutics
RLAY
$619M
| $11.1M | 0.26% | 673,966 | – | – |
|